| | MAPK Inhibitors and Activators
- 5-Iodotubercidin
Potent and competitive inhibitor of MAP Kinase ERK2. Inhibitor of Adenosine Kinase and Ser/Thr-specific kinases (casein kinase 1 and PKA).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-3531 | 24386-93-4 | C11H13IN4O4 | 1 mg/5 mg |
- AG 126
Blocks production of tumor necrosis factor-α (TNF-α) and nitric oxide in macrophages. AG-126 prevents lipopolysaccharide-induced lethal toxicity in mice by blocking tyrosine phosphorylation of p42 MAPK protein substrate.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-3528 | 118409-62-4 | C10H5N3O3 | 5 mg/25 mg |
- CAY10571
Pyridinylimidazoles, often called CSAIDs, are a class of anti-inflammatory compounds that suppress the synthesis of cytokines in human monocytes and inhibit eicosanoid productio. Because of its high specificity, one predominant pyridinylimidazole, SB203580, is frequently used to inhibit p38 MAPK, the tyrosine kinase activated by inflammatory cytokines and environmental stresses. CAY10571 is an analog of SB203580 that inhibits IL-1 production in the human monocytic cell line THP with an IC50 value of 0.20 µM and binds CSAID binding protein, a serine/threonine kinase homologous to p38, inhibiting its kinase activity with an IC50 value of 0.03 µM. This chemical also inhibits 5-lipoxygenase production in RBL-1 cells with an IC50 value of 24 µM.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-223869 | 152121-46-5 | C21H16FN3O2S | 5 mg/10 mg |
- CGP 57380
A selective inhibitor of mitogen-activated protein kinase-interacting kinase 1 (MNK1). Effectively inhibits eIF4E phosphorylation.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202993 | 522629-08-9 | C11H9FN6 | 5 mg |
- Coumermycin A1
Shown to be a cell permeable antibiotic that induces activation of JAKs via autophosphorylation. Also reported to cause cell proliferation. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200882 | 4434-05-3 | C55H59N5O20 | 5 mg/25 mg |
- U-0126
A selective MAPK and ERK inhibitor, displaying a preference for MEK1 and MEK2.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-222395 | 109511-58-2 | C18H16N6S2 | 1 mg/5 mg |
- ERK Inhibitor II, FR180204
A novel ERK-selective inhibitor that can permeate the cell. The compound has been reported to inhibit ERK1 (Ki=0.31μM), ERK2 (Ki=0.14 μM), TGFβ-induced AP-1 activation and acts as a competitive inhibitor of ATP. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203945 | 865362-74-9 | C18H13N7 | 1 mg |
- GW 5074
An Inhibitor of Raf-1 kinase, PMA-mediated activation of ERK1/2, and blocks neurodegeneration. Used in Ras/Raf-1/ERK pathway studies.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200639 | 220904-83-6 | C15H8Br2INO2 | 5 mg/25 mg |
- JX-401
JX-401 is a potent reversible inhibitor of p38alpha by reversibly binding MAPK p38alpha and has blocked differentiation of L8 myoblasts to myotubes.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200687 | 349087-34-9 | C21H25NO2S | 1 mg/10 mg |
- MK2a Inhibitor
A p-amidophenolic compound that selectively inhibits the phosphorylation of MK2a by p38α in a non-ATP-competitive manner. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203138 | 41179-33-3 | C22H20FNO2 | 10 mg |
- p38 MAP Kinase Inhibitor
A potent p38 MAP kinase inhibitor (IC50 = 35 nM).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204157 | 219138-24-6 | C20H13ClFN3O | 500 µg |
- p38 MAP Kinase Inhibitor III
Methylsulfanylimidazole compount that is cell-permeable and acts as a potent, selective, and ATP competitive p38 MAP kinase inhibitor. Has been shows to effectively suppress LPS-induced cytoking release in vitro and in vivo. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204158 | 581098-48-8 | C23H21FN4S | 1 mg |
- p38 MAP Kinase Inhibitor IV
A cell permeable sulfone compound which functions as an ATP-competitive inhibitor of p38α and p38β MAP Kinases.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204159 | 1638-41-1 | C12H4Cl6O4S | 10 mg |
- p38 MAP Kinase Inhibitor V
A cell-permeable trisubstituted pyrazole compound that acts as a highly potent ATP-competitive inhibitor of CK1 and p38.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204160 | 271576-77-3 | C19H20ClN5 | 1 mg |
- p38 MAP Kinase Inhibitor VIII
A synthetic 4-aminobenzophenone small molecule inhibitor of p38α and p38β MAP kinase. Blocks the release of TNF-α and proinflammatory interleukins.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203173 | 321351-00-2 | C20H16BrClN2O | 5 mg |
- PD 169316
A potent, cell-permeable, and selective p38 MAP kinase inhibitor (IC50 = 89 nM). Inhibition of p38 MAP kinase by PD 169316 blocks apoptosis induced by trophic factor withdrawal in non-neuronal and neuronal cell lines.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204168 | 152121-53-4 | C20H13FN4O2 | 1 mg |
- PD 184,352
An inhibitor of MEK, blocks MAPK activity and slows proliferation of colon tumor cells in mice.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202759 | 212631-79-3 | C17H14ClF2IN2O2 | 1 mg/5 mg |
- PD 184161
A strong and selective inhibitor of MEK1/2; more effective at inhibiting phosphorylation of ERK1/2 than the selective MEK inhibitors, PD098059 and U0126.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-222141 | 212631-67-9 | C17H13BrClF2IN2O2 | 1 mg/5 mg |
- PD 198306
Cell-permeable amino-benzamide compound that acts as a potent and non-ATP-competitive inhibitor of MEK1/2.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203180 | 212631-61-3 | C18H16F3IN2O2 | 5 mg |
- PD 98059
PD 98059 is a potent, selective and reversible cell permeable inhibitor of MEK-1, inducer of GSTA2 and enhancer of glutathione.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-3532 | 167869-21-8 | C16H13NO3 | 1 mg/5 mg |
- SB 202190
A pyridinyl imidazole that inhibits the p38 pathway. It can also induce apoptosis, and phosphorylate and activate MLK3. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202334 | 152121-30-7 | C20H14FN3O | 1 mg/5 mg |
- SB 203580
Highly specific inhibitor of p38 MAP kinase. Blocks activation of MAPKAP Kinase-2, yet does not disrupt JNK activity. A useful tool to assess the physiological roles of p38, and for deriving and maintaining embryonic stem cells.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-3533 | 152121-47-6 | C21H16FN3OS | 1 mg/5 mg |
- SB 203580 (hydrochloride)
A pyridinyl imidazole inhibitor that can suppress proliferative activity on cytokine-activated lymphocytes. Additionally found to inhibit MAPKs.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204900 | 869185-85-3 | C21H16FN3OS ·HCl | 5 mg/10 mg |
- SB 239063
| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-220094 | 193551-21-2 | C20H21FN4O2 | 5 mg/25 mg |
- SB220025
Potent and specific inhibitor of human p38 (SAPK2a). Potent inhibitor of angiogenesis and as an inhibitor of TNF-α production.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-202804 | 165806-53-1 | C18H19FN6 | 500 µg |
- SD-169
A compound that inhibits p38α MAPK and acts as an ATP competitive inhibitor of p38 kinase. Described to decrease the expression of HSP60, insulitis, and beta cell death.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200693 | 1670-87-7 | C9H8N2O | 10 mg/50 mg |
- SL-327
A selective inhibitor of MEK1 and MEK2. Also inhibits ERK1, MEK-3/p38, MEK-4, JNK, and PKC at higher concentrations.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200685 | 305350-87-2 | C16H12F3N3S | 1 mg/10 mg |
- XRP44X
Ras-Net (Elk-3) pathway inhibitor (IC50 = 10-20 nM). Indirectly inhibits Net phosphorylation upstream of Erk1/2 activation. Mediates G2-M cell cycle arrest. Suppresses growth of multiple cell types (IC50 ~ 2 nM). Inhibits angiogenesis and acts as a microtubule depolymerizing agent in vitro.
| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204404 | 729605-21-4 | C21H21ClN4O | 10 mg/50 mg |
|